HELSINKI, October 30 /PRNewswire/ -- Biohit has launched a new autoclavable mechanical pipette range, the Proline Plus family.

(Photo: Photo: )

In the new Proline Plus pipettor, Biohit has combined the basic functionalities of the traditional Proline mechanical with new, state-of-the-art pipettor design and technology. Particular emphasis has been put on safety, ergonomics, and efficiency in pipetting, as well as on the high quality of the device. Novelties - compared with the regular Biohit Proline - include a more ergonomic design, reduced pipetting force, autoclavability, and improved UV light resistance, as well as easier and faster maintenance.

Proline Plus is a mechanical liquid handling device with a robust design suitable for all types of applications. The new pipettor allows for accurate and precise results with low pipetting force. The slim tip ejector collar fits also narrow tubes.

The new Proline Plus is fully autoclavable and resistant to UV light and a wide range of chemicals. It is also easy to maintain and calibrate, as no opening tools are needed and only 3-4 parts need to be cleaned. Additionally, the pipettors are equipped with replaceable tip cone filters that give additional protection against contamination thus improving the quality and safety of pipetting.

Proline Plus is available in both adjustable single and multichannel models and fixed volume single-channel models, in volume ranges from 0.1 micro litres to 10 ml. Like all other mechanical pipettors from Biohit, also Proline Plus is CE/IVD marked and comes with a 3-year warranty.

The new Proline Plus will be showcased at Medica, Dusseldorf, Germany, 14th to 17th November, hall 2, booth 2A49

About Biohit Oyj

Finnish company Biohit Oyj (HEX: BIOBV) develops, manufactures and markets liquid handling products and diagnostic test systems for use in research, health care and industrial laboratories.

Liquid handling products include electronic and mechanical pipettors and disposable tips, and pipettor maintenance and calibration services. Diagnostics business comprises products and analysis systems for diagnosing, screening and prevention of gastrointestinal diseases, e.g. the blood-sample based GastroPanel, for diagnosing diseases of the stomach and associated risks, as well as biopsy specimen quick tests for the diagnosis of lactose intolerance and H. pylori infection.

Headquartered in Finland, Biohit has subsidiaries in France, Germany, the UK, Russia, China, Japan and the USA. Additionally, Biohit has approximately 450 distributors in 70 countries. See

Further information: Kati Andersin, Product Group Manager, Tel: +358-9-7738-6378,